These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24107875)

  • 1. [Piascledin in the treatment of chronic dorsalgia].
    Merkulova DM; Onsin AA; Merkulov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):18-22. PubMed ID: 24107875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nonspecific low-back pain: from symptomatic treatment to pathogenesis-based treatment].
    Alekseev VV; Alekseev AV; Gol'dzon GD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):51-5. PubMed ID: 24662346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of ketoprofen lysine salt (artrosilene) in the treatment of nonspecific vertebrogenic pain syndromes in outpatients].
    Trubetskaia EA; Boĭko AN; Khozova A; Kamchatnov PR; Petrov SV; Otcheskaia OV; Gandzhula PA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):53-5. PubMed ID: 23528496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of piascledine treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Piascledine in the treatment of parodontopathies].
    Jarzab G
    Czas Stomatol; 1975 Apr; 28(4):443-5. PubMed ID: 1055040
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Honvo G; Reginster JY; Rabenda V; Geerinck A; Mkinsi O; Charles A; Rizzoli R; Cooper C; Avouac B; Bruyère O
    Drugs Aging; 2019 Apr; 36(Suppl 1):65-99. PubMed ID: 31073924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapeutic possibilities in the treatment of arthrosis].
    Avouac B
    Rev Prat; 2002 Mar; 52(5 Suppl):S7-10. PubMed ID: 11949495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ketoprofen lysine treatment of painful manifestations of spinal osteoarthrosis].
    Memeo A; Cosentina R
    Clin Ter; 1988 Jul; 126(2):119-22. PubMed ID: 2974377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Piascledine in the treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of a new foam formulation of ketoprofen lysine salt in experimental models of inflammation and hyperalgesia.
    Daffonchio L; Bestetti A; Clavenna G; Fedele G; Ferrari MP; Omini C
    Arzneimittelforschung; 1995 May; 45(5):590-4. PubMed ID: 7541996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of general drugs other than antibiotics in periodontitis].
    Viargues P
    Actual Odontostomatol (Paris); 1991 Mar; 45(173):45-61. PubMed ID: 1853744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability 80 mg granulated ketoprofen lysine salt in posttraumatic orodental pain: double blind vs placebo study].
    Balzanelli B; de Lorenzi C
    Minerva Stomatol; 1996; 45(1-2):53-9. PubMed ID: 8741094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical compatibility between ketoprofen lysine salt injections (Artrosilene) and pharmaceutical products frequently used for combined therapy by intravenous administration.
    Anacardio R; Perilli O; Bartolini S; Gentile MM; Mazzeo P; Carlucci G
    J Pharm Biomed Anal; 2003 Aug; 32(6):1235-41. PubMed ID: 12907268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of unsaponifiable extracts of avocado and soybean (Piasclédine) on the collagenolytic action of cultures of human rheumatoid synoviocytes and rabbit articular chondrocytes treated with interleukin-1].
    Mauviel A; Loyau G; Pujol JP
    Rev Rhum Mal Osteoartic; 1991 Apr; 58(4):241-5. PubMed ID: 1647544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of and tolerance for ketoprofen lysine salt in solution for oropharyngeal use in inflammatory lesions of the oral cavity].
    Natale F; de' Lorenzi C
    Minerva Stomatol; 1997 May; 46(5):273-8. PubMed ID: 9265098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerability of ketoprofen lysine salt foam for topical use in the treatment of traumatic pathologies of the locomotor apparatus].
    Parrini M; Cabitza P; Arrigo A; Vanasia M
    Clin Ter; 1992 Sep; 141(9):199-204. PubMed ID: 1458806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies of the small intestine mucosa after an oral administration of Piasclédine (author's transl)].
    Czerny K; Matysiak W; Chabros E
    Ann Univ Mariae Curie Sklodowska Med; 1978; 33():327-32. PubMed ID: 161961
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complex therapy of acute and chronic back pain with dexalgin].
    Barulin AE; Kurushina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):61-4. PubMed ID: 23257750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic effect of dexalgin on disturbances of vertebrogenic and nonvertebrogenic mechanisms in back pain].
    Merkulov IuA; Merkulova DM; Kryzhanovskiĭ GN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):20-4. PubMed ID: 16768220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and tolerability of ketoprofen lysine, once a day, in patients with rheumatic disorders.
    Chevallard M; Mele G; Borsa M; Malandrino S; Tonon GC; Carrabba M
    Drugs Exp Clin Res; 1987; 13(5):293-6. PubMed ID: 3119304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.